Health
FDA Approves Sunharbo, the First Factor XIa Blood Thinner, to Cut the Risk of Repeat Strokes
The FDA has approved Sunharbo (asundexian), the first Factor XIa inhibitor, to cut the risk of a second…
The FDA has approved Sunharbo (asundexian), the first Factor XIa inhibitor, to cut the risk of a second…